ClinicalTrials.Veeva

Menu

Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions

Henry Ford Health logo

Henry Ford Health

Status

Completed

Conditions

Exacerbation of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease

Treatments

Behavioral: Bundle tool

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Hospital readmissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) pose burdens to the healthcare system and patients. The aim of this study was to determine whether a screening and educational tool, administered prior to discharge, would result in a decrease in the rate of hospital readmissions.

Full description

Hospital readmissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) pose burdens to the healthcare system and patients. A current gap in knowledge is whether a pre-discharge screening and educational tool, administered to patients with COPD, reduces readmissions and emergency department (ED) visits.

A single center, randomized trial of patients admitted with AECOPD. Patients will be randomized to control (standard care) or "bundle" group in which patients receive smoking cessation counseling, screening for gastroesophageal reflux disease and depression or anxiety, standardized inhaler teaching, and a 48-hour post-discharge phone call.

Enrollment

172 patients

Sex

All

Ages

40 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of COPD with the presence of an AECOPD
  • Age > 40
  • Current or ex-smoker with history of at least 20 pack-years

Exclusion criteria

  • Past history of asthma, interstitial lung disease, bronchiectasis, presence of airway hardware (e.g. tracheal stents or tracheotomy), lung cancer, any other cancer with a life expectancy of less than 1 year
  • Presence of a language barrier
  • Residence in a nursing home
  • Intensive care unit stay during the current admission
  • Delirium or dementia.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

172 participants in 2 patient groups

Control
No Intervention group
Description:
Group of patients undergo standard care as determined by the primary inpatient team
Bundle
Experimental group
Description:
Group of patients that receive the screening and educational tool
Treatment:
Behavioral: Bundle tool

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems